238. S.J. Yue, J.N. An, Y.F. Zhang, J.Y. Li, C.Z. Zhao, J.Y. Liu, L.L. Liang, H.L. Sun*, Y. Xu*, Z.Y. Zhong*, Exogenous Antigen Upregulation Empowers Antibody Targeted Nanochemotherapy of Leukemia, Adv. Mater. 2023, 2209984.238.pdf

237. R. Huang, H. Du, L. Cheng, P.Z. Zhang, F.H. Meng*, Z.Y. Zhong*, Targeted nanodelivery of siRNA against KRAS G12D inhibits pancreatic cancer, Acta Biomaterialia 2023, 168, 529-539.237.pdf

236. Q. Yuan, D.Y. Fan, Y.F. Zhang, S.J. Yue, R. Cheng, Z.Y. Zhong*, H.L. Sun*, CD38-selective immuno-nano-DM1 conjugates for depleting multiple myeloma, Biomater. Sci. 2023, 11, 4985-4994.236.pdf

235. J.W. Du, S.J. Yue, C.M. Li, J.Y. Li, S.S. Zhao, Y.Y. Dong, Y.F. Zhang, R. Cheng, H.L. Sun*, Z.Y. Zhong*, Exogenous CD38 upregulation enables high-efficacy dually cascade targeted molecular therapy of leukemia, Nano Today 2023, 50, 101872.235.pdf

234. W.C. Yan, B.B. Guo, Z. Wang a, J.T. Yang, Z.Y. Zhong*, F.H. Meng*, RGD-directed 24 nm micellar docetaxel enables elevated tumor-liver ratio, deep tumor penetration and potent suppression of solid tumors, J. Control. Release 2023, 360, 304-315.234.pdf

233. Y.J. Li, X.Y. Li, J.M. Yi, Y.J. Cao, Z.H. Qin*, Z.Y. Zhong*, W.J. Yang*, Nanoparticle-Mediated STING Activation for Cancer Immunotherapy, Adv. Healthc. Mater. 2023, 2300260.233.pdf

232. M.Y. He, M.Y. Wang, T.Xu, M.Y. Zhang, H.X. Dai, C. Wang*, D.W. Ding*,Z.Y. Zhong*, Reactive oxygen species-powered cancer immunotherapy: Current status and challenges, J. Control. Release 2023, 356, 623-648.232.pdf

231. J.G. Xie, X.F. Zhao, P. Zhang, Y.Y. Zhang, R. Cheng, Z.Y. Zhong*, C. Deng*, Codelivery of BCL2 and MCL1 Inhibitors Enabled by Phenylboronic Acid-Functionalized Polypeptide Nanovehicles for Synergetic and Potent Therapy of Acute Myeloid Leukemia, Adv. Sci. 2023, 10, 202204866.231.pdf

230. L. Yang, Y.J. Sha, Y.S. Wei, H.H. Fang, J.J. Jiang, L.C. Yin, Z.Y. Zhong*, F.H. Meng*, Mannose-mediated nanodelivery of methotrexate to macrophages augments rheumatoid arthritis therapy, Biomater. Sci. 2023, 11, 2211-2220.230.pdf

229. B.B. Guo, Y. Qu, Y.P. Sun, S.S. Zhao, J.D. Yuan, P.Z. Zhang, Z.Y. Zhong*, F.H. Meng*, Co-delivery of gemcitabine and paclitaxel plus NanoCpG empowers chemoimmunotherapy of postoperative cold triple-negative breast cancer, Bioactive Mater. 2023, 25, 61-72.229.pdf

228. Y.P. Sun, Y.J. Sha, G.H. Cui, F.H. Meng*, Z.Y. Zhong*, Lysosomal-mediated drug release and activation for cancer therapy and immunotherapy, Adv. Drug Deliv. Rev. 2023, 192, 114624.228.pdf

227. Y.F. Xia, J.N. An, J.Y. Li, W.X. Gu, Y.F. Zhang, S.S. Zhao, C.Z. Zhao, Y. Xu, B. Li, Z.Y. Zhong*, F.H. Meng*, Transferrin-guided intelligent nanovesicles augment the targetability and potency of clinical PLK1 inhibitor to acute myeloid leukemia, Bioactive Mater. 2023, 21, 499-510.227.pdf